The timing of autologous stem cell transplantation and the prognostic factors affecting the prognosis in children with relapsed Hodgkin lymphoma.

about

Prognostic Factors and a New Prognostic Index Model for Children and Adolescents with Hodgkin's Lymphoma Who Underwent Autologous Hematopoietic Stem Cell Transplantation: A Multicenter Study of the Turkish Pediatric Bone Marrow Transplantation Study

P2860

Q37548240-FE0B6993-AFFF-4357-A399-6325C68FFA41

P2860

The timing of autologous stem cell transplantation and the prognostic factors affecting the prognosis in children with relapsed Hodgkin lymphoma.

Item

http://www.wikidata.org/entity/Q41265178

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

The timing of autologous stem ...... ith relapsed Hodgkin lymphoma.

@en

type

Item

label

The timing of autologous stem ...... ith relapsed Hodgkin lymphoma.

@en

prefLabel

The timing of autologous stem ...... ith relapsed Hodgkin lymphoma.

@en

P1476

The timing of autologous stem ...... ith relapsed Hodgkin lymphoma.

@en

P2093

Canan Akyüz

http://www.w3.org/2001/XMLSchema#string

Erman Ataş

http://www.w3.org/2001/XMLSchema#string

Nadir Korkmazer

http://www.w3.org/2001/XMLSchema#string

Oğuzhan Babacan

http://www.w3.org/2001/XMLSchema#string

Vural Kesik

http://www.w3.org/2001/XMLSchema#string

P2860

Outcomes for children and adolescents with cancer: challenges for the twenty-first century.

Initial response to salvage therapy determines prognosis in relapsed pediatric Hodgkin lymphoma patients

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial.

Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy.

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial.

Autologous peripheral blood stem cell transplantation in children with refractory or relapsed lymphoma: results of Children's Oncology Group study A5962.

Haematopoietic SCT for children and adolescents with relapsed and refractory Hodgkin's lymphoma.

A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425.

Outcome of hematopoietic stem cell transplant as salvage therapy for Hodgkin's lymphoma in adolescents and young adults at a single institution.

Salvage therapy of progressive and recurrent Hodgkin's disease: results from a multicenter study of the pediatric DAL/GPOH-HD study group.

P304

380-384

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/PETR.12449

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25752654

http://www.w3.org/2001/XMLSchema#string

The timing of autologous stem cell transplantation and the prognostic factors affecting the prognosis in children with relapsed Hodgkin lymphoma.

about

P2860

P2860

The timing of autologous stem cell transplantation and the prognostic factors affecting the prognosis in children with relapsed Hodgkin lymphoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698